ASX Announcements
Compumedics named as one of Australia’s Top 100 Health Innovators 5 Mar 2010 Leading Australia-based medical diagnostic devices Company, Compumedics Limited (ASX: CMP) is pleased to announce it has been recognised as one of Australia’s Top 100 Health Innovators through its world leading devices for sleep diagnostics. CLICK HERE TO READ THE ARTICLE BY "AUSTRALIAN INNOVATION" The list was compiled by the Powerhouse Museum in New South Wales, Australia. In commenting on the determination of factors relevant in gaining this recognition, Debbie Rudder, Curator of Power Technologies, Powerhouse Museum said, “To decide what is worth adding, I stuck to the criteria we used for the web list: originality and impact. Was the idea behind an innovation a significant breakthrough? Did a new product create or boost an industry or earn a good deal of export income? Did a product or social innovation change people's lives?” Recognition of this type follows a string of previous accolades awarded to the company which include: - June, 2009, Compumedics’ world first high-definition sleep diagnostic amplifier, Grael™HD-PSG was awarded the Powerhouse Museum Award 2009 for design excellence and innovative use of technologies
- 2008, its wholly owned Germany subsidiary, Compumedics Germany GmbH was admitted to Germany’s high-technology élite with the award of membership of Germany’s top 100 innovative companies.
Executive Chairman, CEO, Compumedics, David Burton said, “We have been in business now for over 20 years and have worked hard to build a profitable and sustainable business for shareholders and other stakeholders. It is always a bonus to gain some outside recognition and support for what we do. Compumedics is proud of the contributions it makes to the wider community and how we can actually change the quality of people’s lives with our innovative suite of products.” For Further information: Mr David Burton Mr David Lawson
Executive Chairman, CEO Chief Financial Officer
Phone: + 61 3 8420 7300 Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399 Fax: +61 3 8420 7399
Investor Relations & Media Enquires: Mr Rod North
Executive Director
Bourse Communications Pty Ltd
Phone: +61 3 9510 8309
Mobile: +61 (0) 408 670 706 About Compumedics Compumedics Limited, founded in 1987, is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology.
In 1987, Compumedics established Asia Pacific’s first fully computerised sleep laboratory. Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices.
In 1995, the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe the products are distributed in over 50 countries.
In 1998, Compumedics was awarded the overall Australian Exporter of the Year.
In 2000, Compumedics was listed on the Australian Stock Exchange.
In 2002, Compumedics acquired US-based Neuroscan - the world's leading supplier of instruments for brain-research. In the US - the world's largest medical device market - Neuroscan holds around 90% of the market for brain-research products.
In 2003, Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy.
In 2004, Compumedics acquired German-based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields.
In 2006, Compumedics was awarded the Frost and Sullivan Technology Leadership award for the innovative Somté recorder product.
In 2007, Compumedics and Chairman were inducted into the Victorian Manufacturing Hall of Fame.
In 2008, the DWL division received the top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics the Compumedics sales have grown more than 4 fold from $9 million (1999) to $39 million (2008).
In 2009, Compumedics was awarded a design award for its Grael™ PSG/EEG premium laboratory based product. Visit : www.compumedics.com for more information  Back
|
